Analysis of a publicly available gene expression data set (GSE1084638) showed that, across the entire cohort of patients with DLBCL, those expressing TBK1 at levels greater than the median had significantly worse overall survival (log‐rank test, P = .028) (Figure 1A). Here, TBK1 is linked to diffuse large B-cell lymphoma.